Contineum Therapeutics, Inc. (CTNM) Tops Q4 EPS by 16c
Tweet
Share
E-mailGet Alerts CTNM Hot Sheet
Join SI Premium – FREE
Contineum Therapeutics, Inc. (NASDAQ: CTNM) reported Q4 EPS of ($0.49), $0.16 better than the analyst estimate of ($0.65).
For earnings history and earnings-related data on Contineum Therapeutics, Inc. (CTNM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Contineum Therapeutics, Inc. (CTNM) Tops Q2 EPS by 4c
- Arbor Realty Trust (ABR) Tops Q2 EPS by 4c
- Global Health Limited (MEDANTA:IN) PT Raised to INR1,660 at Jefferies
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
